Olin (OLN) Expected to Announce Quarterly Earnings on Thursday

Olin (NYSE:OLN) is expected to post its Q4 2025 results after the market closes on Thursday, January 29th. Analysts expect Olin to post earnings of ($0.28) per share and revenue of $1.6092 billion for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Friday, January 30, 2026 at 9:00 AM ET.

Olin (NYSE:OLN) last announced its earnings results on Monday, October 27th. The specialty chemicals company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.31. Olin had a net margin of 0.79% and a return on equity of 3.36%. The company had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same period in the prior year, the business earned ($0.21) earnings per share. Olin’s quarterly revenue was up 7.8% on a year-over-year basis. On average, analysts expect Olin to post $1 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Olin Price Performance

OLN opened at $23.83 on Thursday. The company has a debt-to-equity ratio of 1.49, a current ratio of 1.56 and a quick ratio of 0.89. The stock has a market capitalization of $2.72 billion, a P/E ratio of 51.79, a price-to-earnings-growth ratio of 2.86 and a beta of 1.64. The company’s 50 day simple moving average is $21.23 and its 200-day simple moving average is $21.98. Olin has a one year low of $17.66 and a one year high of $34.52.

Olin Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 12th. Shareholders of record on Friday, November 28th were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, November 28th. This represents a $0.80 annualized dividend and a yield of 3.4%. Olin’s dividend payout ratio is currently 173.91%.

Analyst Ratings Changes

Several equities research analysts have recently commented on OLN shares. Bank of America lifted their target price on Olin from $25.00 to $30.00 and gave the company a “buy” rating in a research note on Tuesday, October 14th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Olin in a research report on Wednesday, October 8th. Fermium Researc raised Olin to a “strong-buy” rating in a report on Thursday, September 25th. Mizuho set a $26.00 target price on shares of Olin in a research note on Friday, October 3rd. Finally, Citigroup lifted their price target on shares of Olin from $21.00 to $24.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 13th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $24.29.

Insiders Place Their Bets

In other news, VP Teresa M. Vermillion sold 4,500 shares of Olin stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $20.86, for a total transaction of $93,870.00. Following the transaction, the vice president directly owned 17,199 shares of the company’s stock, valued at $358,771.14. This trade represents a 20.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 1.60% of the company’s stock.

Institutional Trading of Olin

Hedge funds have recently added to or reduced their stakes in the business. CIBC Bancorp USA Inc. acquired a new position in Olin in the third quarter valued at about $5,673,000. NewEdge Advisors LLC lifted its holdings in shares of Olin by 45.0% during the 3rd quarter. NewEdge Advisors LLC now owns 2,323 shares of the specialty chemicals company’s stock valued at $58,000 after purchasing an additional 721 shares in the last quarter. CANADA LIFE ASSURANCE Co lifted its holdings in shares of Olin by 1.9% during the 3rd quarter. CANADA LIFE ASSURANCE Co now owns 70,991 shares of the specialty chemicals company’s stock valued at $1,735,000 after purchasing an additional 1,333 shares in the last quarter. Dark Forest Capital Management LP acquired a new position in shares of Olin in the 3rd quarter valued at approximately $1,230,000. Finally, Alyeska Investment Group L.P. increased its stake in Olin by 1.2% during the 3rd quarter. Alyeska Investment Group L.P. now owns 395,366 shares of the specialty chemicals company’s stock worth $9,880,000 after purchasing an additional 4,587 shares in the last quarter. Institutional investors and hedge funds own 88.67% of the company’s stock.

Olin Company Profile

Olin Corporation is a diversified manufacturer specializing in chemical products and ammunition. The company’s core business activities encompass the production and distribution of chlor-alkali products, epoxy resins and derivatives, and small-caliber ammunition under the Winchester brand. Olin’s chemical operations supply chlorine, caustic soda and related co-products to a wide range of end markets, including water treatment, pulp and paper, pharmaceuticals and general industrial applications.

In its Chlor Alkali Products & Vinyls segment, Olin operates multiple manufacturing facilities that produce chlorine and sodium hydroxide, along with vinyl chloride monomer and polyvinyl chloride (PVC) compounds.